(5,10,15,20-Tetrakis(1,3-diethylimidazolium-2-YL)porphyrinato) manganese(III)pentachloride
AEOL 10150 is developed by Aeolus as a therapeutic agents based on its proprietary small molecule catalytic antioxidants.